CUL3 mutation or down-regulation is observed in different types of cancer including lung cancer, oral squamous cell carcinoma and other squamous cell cancers, sporadic PRCC2 (type 2 papillary renal cell carcinoma) and liver cancer (25–28). This evidence concerns the gene CUL3 and squamous cell carcinoma.